Is it appropriate to give a 76-year-old woman with severe vitamin D deficiency a loading dose of vitamin D3 50,000 IU?

Yes, Vitamin D3 50,000 IU Weekly is Appropriate and Safe for Severe Vitamin D Deficiency in a 76-Year-Old Woman

For adults with severe vitamin D deficiency, treatment with 50,000 IU of vitamin D3 once weekly for 8 weeks is the standard, guideline-recommended approach, followed by maintenance therapy of 1,500-2,000 IU daily. 1

Treatment Protocol

Loading Phase (Weeks 1-8)

• Administer 50,000 IU of vitamin D3 (cholecalciferol) once weekly for 8 weeks 1
• This regimen is specifically designed to achieve serum 25(OH)D levels above 30 ng/mL
• The equivalent daily dose would be approximately 6,000 IU/day, but weekly dosing improves adherence 1

Maintenance Phase (After Week 8)

• Continue with 1,500-2,000 IU daily to maintain adequate vitamin D levels 1
• For patients over 75 years, empiric supplementation is recommended due to mortality reduction benefits 2

Safety Considerations

This dosing regimen is well within established safety limits:

• Hypercalcemia from vitamin D toxicity occurs only with daily intake exceeding 100,000 IU or when 25(OH)D levels exceed 100 ng/mL 3
• The tolerable upper limit for adults over 8 years is 10,000 IU daily for correcting deficiency 1
• Weekly dosing of 50,000 IU (equivalent to ~7,000 IU/day) poses no risk of toxicity 3
• No monitoring of serum calcium is required in generally healthy adults during standard repletion 1

Important Caveats

Prefer Weekly Over Large Bolus Doses

• Avoid single annual high doses (500,000 IU), which have been associated with increased falls and adverse outcomes 3, 4
• Weekly or monthly strategies are preferred over very large, infrequent doses 3

Use Vitamin D3, Not D2

• Cholecalciferol (D3) is superior to ergocalciferol (D2) for intermittent dosing regimens 3
• D3 maintains serum levels longer and avoids assay measurement issues 4

Consider Higher Doses If:

The patient may require 2-3 times higher doses (up to 6,000-10,000 IU daily or equivalent) if she has: 1

• Obesity (BMI ≥30)
• Malabsorption syndromes (celiac disease, inflammatory bowel disease, bariatric surgery)
• Medications affecting vitamin D metabolism (anticonvulsants, glucocorticoids, ketoconazole)

In these cases, consider 50,000 IU twice weekly during the loading phase 5

Monitoring Recommendations

For generally healthy older adults:

• Baseline 25(OH)D measurement confirms severe deficiency
• Routine follow-up testing is not necessary if the patient responds clinically 2
• Recheck 25(OH)D only if symptoms persist or compliance is uncertain 1

Monitor serum calcium only if the patient has:

• Primary hyperparathyroidism 1
• Granulomatous diseases (sarcoidosis, tuberculosis) 1
• Lymphoma or conditions with extrarenal 1,25(OH)2D production 1

Calcium Supplementation

• Ensure adequate calcium intake of 1,000-1,200 mg daily (dietary plus supplemental) 4, 6
• Vitamin D requires adequate calcium for optimal bone health outcomes
• This is particularly important if the patient has osteoporosis or osteopenia

Clinical Rationale for This Age Group

At 76 years old, this patient falls into the category where empiric vitamin D supplementation provides mortality benefit 2. The combination of severe deficiency and advanced age makes treatment particularly important for:

• Fall prevention (strong evidence) 1
• Fracture risk reduction (when combined with adequate calcium) 4
• Overall mortality reduction 2

The 50,000 IU weekly regimen for 8 weeks is safe, effective, and represents the standard of care for treating severe vitamin D deficiency in older adults.